(2S,4R)-4-Benzylpyrrolidine-2-carboxylic acid
95%
- Product Code: 233250
CAS:
393524-67-9
| Molecular Weight: | 205.25 g./mol | Molecular Formula: | C₁₂H₁₅NO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD04115788 | |
| Melting Point: | Boiling Point: | 376.9±35.0 °C(Predicted) | |
| Density: | 1.170±0.06 g/cm3(Predicted) | Storage Condition: | Room temperature, light-proof, inert gas |
Product Description:
Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other bioactive molecules. Its stereochemistry makes it valuable for asymmetric synthesis, where it helps control the three-dimensional structure of complex drug candidates. Commonly employed in medicinal chemistry for designing enzyme inhibitors due to its structural similarity to proline, influencing peptide conformation and metabolic stability.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | €357.08 |
+
-
|
| 250mg | 10-20 days | €606.65 |
+
-
|
(2S,4R)-4-Benzylpyrrolidine-2-carboxylic acid
Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other bioactive molecules. Its stereochemistry makes it valuable for asymmetric synthesis, where it helps control the three-dimensional structure of complex drug candidates. Commonly employed in medicinal chemistry for designing enzyme inhibitors due to its structural similarity to proline, influencing peptide conformation and metabolic stability.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :